Atara Biotherapeutics Ownership 2024 | Who Owns Atara Biotherapeutics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

0.13%

Insider Ownership

22.15%

Retail Ownership

77.72%

Institutional Holders

5.00

Atara Biotherapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BOXER CAPITAL, LLC0.12%0.07%166,000-3,984,000-96.00%1,411,000Jun 30, 2024
LAKE STREET ADVISORS GROUP, LLC0.01%0.00%11,000--93,500Jun 30, 2024
IFP ADVISORS, INC0.00%0.00%4,500--1,756Jun 30, 2024
CWM, LLC0.00%-542-19,404-97.28%5,000Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC--3535100.00%344Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----47,731-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----1,351,216-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----6,580,577-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----39,988-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----850,821-100.00%-Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/----4,958,150-100.00%-Jun 30, 2024
STATE STREET CORP----2,489,048-100.00%-Jun 30, 2024
VANGUARD GROUP INC----5,012,938-100.00%-Jun 30, 2024
BARCLAYS PLC----67,661-100.00%-Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC----16,959-100.00%-Jun 30, 2024
FMR LLC----410,678-100.00%-Jun 30, 2024
PINNACLE ASSOCIATES LTD----12,740-100.00%-Jun 30, 2024
LEGAL & GENERAL GROUP PLC----9,047-100.00%-Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND----39,681-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----45,301-100.00%-Jun 30, 2024

Atara Biotherapeutics's largest institutional shareholder is BOXER CAPITAL, LLC, holding 0.12% of the company's total share outstanding, currently valued at $1.41M. The top 10 institutional shareholders own together 0.13% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BOXER CAPITAL, LLC0.12%0.07%166,000-3,984,000-96.00%1,411,000Jun 30, 2024
LAKE STREET ADVISORS GROUP, LLC0.01%0.00%11,000--93,500Jun 30, 2024
IFP ADVISORS, INC0.00%0.00%4,500--1,756Jun 30, 2024
CWM, LLC0.00%-542-19,404-97.28%5,000Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC--3535100.00%344Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----47,731-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----1,351,216-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----6,580,577-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----39,988-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----850,821-100.00%-Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/----4,958,150-100.00%-Jun 30, 2024
STATE STREET CORP----2,489,048-100.00%-Jun 30, 2024
VANGUARD GROUP INC----5,012,938-100.00%-Jun 30, 2024
BARCLAYS PLC----67,661-100.00%-Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC----16,959-100.00%-Jun 30, 2024
FMR LLC----410,678-100.00%-Jun 30, 2024
PINNACLE ASSOCIATES LTD----12,740-100.00%-Jun 30, 2024
LEGAL & GENERAL GROUP PLC----9,047-100.00%-Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND----39,681-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----45,301-100.00%-Jun 30, 2024

The largest Atara Biotherapeutics shareholder by % of total assets is BOXER CAPITAL, LLC. The company owns 166.00K shares of Atara Biotherapeutics (ATRA), representing 0.07% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
EVERSOURCE WEALTH ADVISORS, LLC--3535100.00%344Jun 30, 2024
IFP ADVISORS, INC0.00%0.00%4,500--1,756Jun 30, 2024
LAKE STREET ADVISORS GROUP, LLC0.01%0.00%11,000--93,500Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----23-100.00%-Jun 30, 2024
NISA INVESTMENT ADVISORS, LLC----50-100.00%-Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC----220-100.00%-Jun 30, 2024
AMALGAMATED BANK----3,216-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----5,907-100.00%-Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.----6,782-100.00%-Jun 30, 2024
LEGAL & GENERAL GROUP PLC----9,047-100.00%-Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM----9,736-100.00%-Jun 30, 2024
HSBC HOLDINGS PLC----11,264-100.00%-Jun 30, 2024
NEUBERGER BERMAN GROUP LLC----11,976-100.00%-Jun 30, 2024
PINNACLE ASSOCIATES LTD----12,740-100.00%-Jun 30, 2024
WEALTH ARCHITECTS, LLC----13,277-100.00%-Jun 30, 2024
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC----13,401-100.00%-Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.----16,734-100.00%-Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC----16,959-100.00%-Jun 30, 2024
PROSHARE ADVISORS LLC----17,401-100.00%-Jun 30, 2024
LETKO, BROSSEAU & ASSOCIATES INC----17,500-100.00%-Jun 30, 2024

As of Jun 30 2024, Atara Biotherapeutics's largest institutional buyer is EVERSOURCE WEALTH ADVISORS, LLC. The company purchased 35.00 stocks of ATRA, valued at $344.00.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ECOR1 CAPITAL, LLC----10,167,043-100.00%-Jun 30, 2024
REDMILE GROUP, LLC----9,263,309-100.00%-Jun 30, 2024
BLACKROCK INC.----6,831,479-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----6,580,577-100.00%-Jun 30, 2024
VANGUARD GROUP INC----5,012,938-100.00%-Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/----4,958,150-100.00%-Jun 30, 2024
BOXER CAPITAL, LLC0.12%0.07%166,000-3,984,000-96.00%1,411,000Jun 30, 2024
VESTAL POINT CAPITAL, LP----2,800,000-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC----2,638,687-100.00%-Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC----2,625,468-100.00%-Jun 30, 2024
STATE STREET CORP----2,489,048-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----2,158,591-100.00%-Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC----1,879,923-100.00%-Jun 30, 2024
WOODLINE PARTNERS LP----1,774,802-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----1,351,216-100.00%-Jun 30, 2024
MORGAN STANLEY----1,346,129-100.00%-Jun 30, 2024
STALEY CAPITAL ADVISERS INC----1,000,000-100.00%-Jun 30, 2024
J. GOLDMAN & CO LP----986,651-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----980,385-100.00%-Jun 30, 2024
CHECKPOINT CAPITAL L.P.----892,853-100.00%-Jun 30, 2024

As of Jun 30 2024, Atara Biotherapeutics's biggest institutional seller is ECOR1 CAPITAL, LLC. The company sold -10.17M shares of ATRA, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
EVERSOURCE WEALTH ADVISORS, LLC--3535100.00%344Jun 30, 2024

Atara Biotherapeutics's largest new institutional shareholder by number of shares is EVERSOURCE WEALTH ADVISORS, LLC, purchased 35.00 shares, valued at $344.00, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ECOR1 CAPITAL, LLC----10,167,043-100.00%-Jun 30, 2024
REDMILE GROUP, LLC----9,263,309-100.00%-Jun 30, 2024
BLACKROCK INC.----6,831,479-100.00%-Jun 30, 2024
BANK OF AMERICA CORP /DE/----6,580,577-100.00%-Jun 30, 2024
VANGUARD GROUP INC----5,012,938-100.00%-Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/----4,958,150-100.00%-Jun 30, 2024
VESTAL POINT CAPITAL, LP----2,800,000-100.00%-Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC----2,638,687-100.00%-Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC----2,625,468-100.00%-Jun 30, 2024
STATE STREET CORP----2,489,048-100.00%-Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC----2,158,591-100.00%-Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC----1,879,923-100.00%-Jun 30, 2024
WOODLINE PARTNERS LP----1,774,802-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----1,351,216-100.00%-Jun 30, 2024
MORGAN STANLEY----1,346,129-100.00%-Jun 30, 2024
STALEY CAPITAL ADVISERS INC----1,000,000-100.00%-Jun 30, 2024
J. GOLDMAN & CO LP----986,651-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----980,385-100.00%-Jun 30, 2024
CHECKPOINT CAPITAL L.P.----892,853-100.00%-Jun 30, 2024
NORTHERN TRUST CORP----850,821-100.00%-Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC----761,360-100.00%-Jun 30, 2024
SHAY CAPITAL LLC----438,506-100.00%-Jun 30, 2024
TD ASSET MANAGEMENT INC----436,800-100.00%-Jun 30, 2024
FMR LLC----410,678-100.00%-Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC----383,082-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----361,245-100.00%-Jun 30, 2024
BANK OF NEW YORK MELLON CORP----352,513-100.00%-Jun 30, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE----312,163-100.00%-Jun 30, 2024
ROYAL BANK OF CANADA----287,637-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC----244,257-100.00%-Jun 30, 2024
ALLIANCEBERNSTEIN L.P.----167,200-100.00%-Jun 30, 2024
RHUMBLINE ADVISERS----147,574-100.00%-Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC----147,000-100.00%-Jun 30, 2024
SAVANT CAPITAL, LLC----131,811-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----128,522-100.00%-Jun 30, 2024
HENNION & WALSH ASSET MANAGEMENT, INC.----119,051-100.00%-Jun 30, 2024
UBS GROUP AG----106,465-100.00%-Jun 30, 2024
PRIVATE ADVISOR GROUP, LLC----95,661-100.00%-Jun 30, 2024
VONTOBEL HOLDING LTD.----80,000-100.00%-Jun 30, 2024
BARCLAYS PLC----67,661-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----47,731-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----45,301-100.00%-Jun 30, 2024
MARSHALL WACE, LLP----42,242-100.00%-Jun 30, 2024
DELAP WEALTH ADVISORY, LLC----41,533-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----39,988-100.00%-Jun 30, 2024
NEW YORK STATE COMMON RETIREMENT FUND----39,681-100.00%-Jun 30, 2024
DEUTSCHE BANK AG\----36,353-100.00%-Jun 30, 2024
INVESCO LTD.----34,507-100.00%-Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC----33,767-100.00%-Jun 30, 2024
ATOM INVESTORS LP----31,408-100.00%-Jun 30, 2024
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM----31,145-100.00%-Jun 30, 2024
ENGINEERS GATE MANAGER LP----29,809-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----29,733-100.00%-Jun 30, 2024
PRINCIPAL FINANCIAL GROUP INC----26,591-100.00%-Jun 30, 2024
SVB WEALTH LLC----21,078-100.00%-Jun 30, 2024
RAYMOND JAMES & ASSOCIATES----19,891-100.00%-Jun 30, 2024
LETKO, BROSSEAU & ASSOCIATES INC----17,500-100.00%-Jun 30, 2024
PROSHARE ADVISORS LLC----17,401-100.00%-Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC----16,959-100.00%-Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.----16,734-100.00%-Jun 30, 2024
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC----13,401-100.00%-Jun 30, 2024
WEALTH ARCHITECTS, LLC----13,277-100.00%-Jun 30, 2024
PINNACLE ASSOCIATES LTD----12,740-100.00%-Jun 30, 2024
NEUBERGER BERMAN GROUP LLC----11,976-100.00%-Jun 30, 2024
HSBC HOLDINGS PLC----11,264-100.00%-Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM----9,736-100.00%-Jun 30, 2024
LEGAL & GENERAL GROUP PLC----9,047-100.00%-Jun 30, 2024
AMERITAS INVESTMENT PARTNERS, INC.----6,782-100.00%-Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----5,907-100.00%-Jun 30, 2024
AMALGAMATED BANK----3,216-100.00%-Jun 30, 2024
FARTHER FINANCE ADVISORS, LLC----220-100.00%-Jun 30, 2024
NISA INVESTMENT ADVISORS, LLC----50-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----23-100.00%-Jun 30, 2024

Atara Biotherapeutics's largest sold out institutional shareholder by shares sold is ECOR1 CAPITAL, LLC, sold -10.17M shares, valued at -, as of undefined.

Atara Biotherapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
WASATCH FUNDS TRUST0.72%6,712,677--Mar 31, 2024
Morgan Creek Global Equity Long/Short Institutional Fund0.21%4,063--Mar 31, 2024
FIDELITY ADVISOR SERIES VII0.14%1,180,000--Jan 31, 2024
VANGUARD VALLEY FORGE FUNDS0.12%64,886--Mar 31, 2024
Vanguard Montgomery Funds0.09%22,395--Mar 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.09%17,940--Mar 28, 2024
VANGUARD EXPLORER FUND0.09%1,112,882--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.09%230,000--Mar 31, 2024
Federated Hermes Equity Funds0.07%1,422,365--Jan 31, 2024
PERMANENT PORTFOLIO FAMILY OF FUNDS0.05%525,000--Jan 31, 2024
Harbor ETF Trust0.04%208,827163,946365.29%Jan 31, 2024
Vericimetry Funds0.04%3,940--Mar 31, 2024
VANGUARD HORIZON FUNDS0.03%808,850--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.03%187,044--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.03%544,500--Mar 31, 2024
TOCQUEVILLE TRUST0.03%3,500--Jan 31, 2024
Humankind Benefit Corp0.02%540--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%13,001--Mar 31, 2024
CARILLON SERIES TRUST0.02%1,220,241--Mar 31, 2024
Fidelity Commonwealth Trust II0.02%141,924--Aug 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.02%245,744--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.02%61,800--Feb 29, 2024
ETFis Series Trust I0.02%26,074--Jan 31, 2024
Federated Hermes MDT Series0.02%39,051--Jan 31, 2024
VANGUARD QUANTITATIVE FUNDS0.01%56,400--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,394--Mar 31, 2024
Fidelity Central Investment Portfolios LLC0.01%540,000--Feb 29, 2024
ALGER FUNDS0.01%10,000--Jan 31, 2024
VANGUARD INDEX FUNDS0.01%4,072,072-1,319,210-24.47%Mar 31, 2024
Nushares ETF Trust0.01%66,874--Jan 31, 2024
FEDERATED HERMES INSURANCE SERIES0.01%34,475--Mar 31, 2024
FIDELITY COVINGTON TRUST0.01%140,300-1,624-1.14%Mar 31, 2024
ALPS ETF Trust0.01%90,129--Feb 29, 2024
SCHWAB CAPITAL TRUST0.01%276,743--Jan 31, 2024
JNL VARIABLE FUND LLC0.01%32,822--Mar 31, 2020
Direxion Shares ETF Trust0.00%723,689--Jan 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%225,069--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%817,979-24,764-2.94%Feb 29, 2024
VALIC Co II0.00%104,5473,1203.08%Feb 28, 2021
Calvert Variable Products, Inc.0.00%6,782--Mar 31, 2024
Managed Portfolio Series0.00%53,629--Jan 31, 2024
JPMORGAN TRUST II0.00%2,410,521--Feb 29, 2024
Voya INVESTORS TRUST0.00%114,564-11,207-8.91%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%60,082--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%41,3042,4496.30%Mar 31, 2024
AMG FUNDS III0.00%8,583--Mar 28, 2024
TIAA-CREF LIFE FUNDS0.00%4,344--Mar 31, 2024
SEASONS SERIES TRUST0.00%38,188-2,229-5.52%Mar 31, 2024
FIDELITY ADVISOR SERIES I0.00%289,875--Feb 29, 2024
Principal Exchange-Traded Funds0.00%16,865-2,592-13.32%Mar 31, 2024
OHIO NATIONAL FUND INC0.00%26,563--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%82,240--Feb 29, 2024
BMO FUNDS, INC.0.00%48,458--Nov 30, 2021
SunAmerica Specialty Series0.00%597--Apr 30, 2021
VANGUARD WORLD FUND0.00%277,0331,4880.54%Feb 29, 2024
SSGA FUNDS0.00%489--Feb 29, 2024
PFM Multi-Manager Series Trust0.00%900--Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%33,767-7,074-17.32%Mar 31, 2024
Columbia Funds Variable Series Trust II0.00%33,195--Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%4,598--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%951,414--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%483,513-40,231-7.68%Feb 29, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%3,383--Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%802,646--Jan 31, 2024
NEW COVENANT FUNDS0.00%3,254--Dec 31, 2023
COLUMBIA FUNDS VARIABLE INSURANCE TRUST0.00%391,821--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%30,300--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%37,339--Jan 31, 2024
Voya PARTNERS INC0.00%36,900--Mar 31, 2024
JPMorgan Trust I0.00%522,098--Jan 31, 2024
EQ ADVISORS TRUST0.00%406,06353,70015.24%Mar 31, 2024
NORTHERN FUNDS0.00%45,019-10,187-18.45%Mar 28, 2024
FLEXSHARES TRUST0.00%23,628--Jan 31, 2024
COLUMBIA FUNDS SERIES TRUST I0.00%1,314,215--Feb 29, 2024
THRIVENT SERIES FUND INC0.00%30,349--Mar 28, 2024
THRIVENT MUTUAL FUNDS0.00%25,067--Mar 28, 2024
MAINSTAY VP FUNDS TRUST0.00%32,100--Mar 31, 2024
GLENMEDE FUND INC0.00%2,246--Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%435,30853,94414.15%Feb 29, 2024
iSHARES TRUST0.00%3,548,734-215,010-5.71%Mar 31, 2024
RYDEX SERIES FUNDS0.00%871--Dec 31, 2023
Forethought Variable Insurance Trust0.00%843--Mar 28, 2024
NATIONWIDE MUTUAL FUNDS0.00%26,2407,29738.52%Jan 31, 2024
Guggenheim Active Allocation Fund0.00%1,012--Feb 29, 2024
ALLSPRING MASTER TRUST0.00%10,704--Feb 29, 2024
SPDR SERIES TRUST0.00%5,665,728--Mar 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%13,336--Mar 31, 2024
GPS Funds I0.00%771--Mar 31, 2024
JPMORGAN INSURANCE TRUST0.00%1,710-90-5.00%Mar 31, 2023
VALIC Co I0.00%37,168-150-0.40%Feb 29, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%6,563--Dec 31, 2023
Meeder Funds0.00%580--Mar 31, 2024
MAINSTAY FUNDS TRUST0.00%23,039--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%14,299--Mar 31, 2024
RYDEX DYNAMIC FUNDS0.00%432--Dec 31, 2023
PENN SERIES FUNDS INC0.00%2,928--Mar 28, 2024
J.P. Morgan Exchange-Traded Fund Trust0.00%35,262--Jan 31, 2024
AMERICAN CENTURY ETF TRUST0.00%8,836--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%169,991-11,182-6.17%Mar 31, 2024
ProFunds0.00%752-63-7.73%Mar 31, 2024

Atara Biotherapeutics's largest mutual fund holder by % of total assets is "WASATCH FUNDS TRUST", owning 6.71M shares, compromising 0.72% of its total assets.

Atara Biotherapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 245-93.98%
31 Mar, 2483-9.78%
31 Dec, 2392-19.30%
30 Sep, 23114-7.32%
30 Jun, 23123-3.91%
31 Mar, 23128-9.86%
31 Dec, 22142-7.19%
30 Sep, 2215312.50%
30 Jun, 22136-5.56%
31 Mar, 221440.70%
31 Dec, 211430.70%
30 Sep, 21142-2.07%
30 Jun, 21145-4.61%
31 Mar, 21152-1.30%
31 Dec, 201546.94%
30 Sep, 2014412.50%
30 Jun, 201289.40%
31 Mar, 20117-4.88%
31 Dec, 191230.82%
30 Sep, 19122-3.94%
30 Jun, 191270.79%
31 Mar, 19126-
31 Dec, 181264.13%
30 Sep, 18121-13.57%
30 Jun, 181408.53%
31 Mar, 1812946.59%
31 Dec, 17884.76%
30 Sep, 1784-6.67%
30 Jun, 17902.27%
31 Mar, 17883.53%
31 Dec, 168514.86%
30 Sep, 16741.37%
30 Jun, 1673-
31 Mar, 1673-17.98%
31 Dec, 1589-4.30%
30 Sep, 159319.23%
30 Jun, 157847.17%
31 Mar, 155335.90%
31 Dec, 1439-

As of 30 Jun 24, 5 institutions are holding Atara Biotherapeutics's shares, representing a decrease of -93.98% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 24182,077-99.78%
31 Mar, 2483,283,24828.68%
31 Dec, 2364,720,313-26.10%
30 Sep, 2387,581,757-3.19%
30 Jun, 2390,465,542-11.89%
31 Mar, 23102,671,7225.47%
31 Dec, 2297,347,726-2.51%
30 Sep, 2299,854,2400.06%
30 Jun, 2299,795,4551.98%
31 Mar, 2297,854,1682.80%
31 Dec, 2195,193,1636.14%
30 Sep, 2189,688,1814.34%
30 Jun, 2185,960,524-0.73%
31 Mar, 2186,592,906-0.02%
31 Dec, 2086,611,5055.12%
30 Sep, 2082,396,7466.21%
30 Jun, 2077,576,36123.18%
31 Mar, 2062,978,1813.03%
31 Dec, 1961,124,2193.58%
30 Sep, 1959,010,00617.32%
30 Jun, 1950,296,6313.05%
31 Mar, 1948,808,9201.15%
31 Dec, 1848,254,0454.11%
30 Sep, 1846,348,383-0.23%
30 Jun, 1846,455,5846.50%
31 Mar, 1843,618,52446.14%
31 Dec, 1729,847,30712.26%
30 Sep, 1726,588,7143.29%
30 Jun, 1725,741,6927.25%
31 Mar, 1724,002,5333.31%
31 Dec, 1623,232,7813.72%
30 Sep, 1622,400,3252.78%
30 Jun, 1621,794,93010.03%
31 Mar, 1619,807,4022.82%
31 Dec, 1519,264,206-1.34%
30 Sep, 1519,526,63448.02%
30 Jun, 1513,191,58117.49%
31 Mar, 1511,227,49366.94%
31 Dec, 146,725,410-

Atara Biotherapeutics (ATRA) has 182.08K shares outstanding as of 30 Jun 24, down -99.78% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 240.13%0.00%
31 Mar, 2478.63%2.13%
31 Dec, 2360.83%0.88%
30 Sep, 2383.34%1.10%
30 Jun, 2387.01%0.89%
31 Mar, 2398.75%1.11%
31 Dec, 2294.35%0.99%
30 Sep, 2297.49%1.01%
30 Jun, 2298.22%1.04%
31 Mar, 2297.15%0.94%
31 Dec, 21101.63%1.11%
30 Sep, 2195.82%1.10%
30 Jun, 2193.28%1.04%
31 Mar, 2194.68%0.92%
31 Dec, 20101.54%0.99%
30 Sep, 20101.50%0.78%
30 Jun, 20114.12%1.08%
31 Mar, 20102.89%0.92%
31 Dec, 19106.00%0.92%
30 Sep, 19107.45%0.92%
30 Jun, 19108.34%0.97%
31 Mar, 19105.82%0.95%
31 Dec, 18105.41%1.01%
30 Sep, 18102.08%0.93%
30 Jun, 18104.68%0.86%
31 Mar, 18110.16%1.10%
31 Dec, 1799.95%1.31%
30 Sep, 1787.25%1.13%
30 Jun, 1788.01%1.29%
31 Mar, 1782.61%1.28%
31 Dec, 1680.35%1.33%
30 Sep, 1677.78%1.35%
30 Jun, 1676.03%1.58%
31 Mar, 1669.40%1.51%
31 Dec, 1567.80%1.36%
30 Sep, 1570.56%2.38%
30 Jun, 1554.46%2.08%
31 Mar, 1551.22%2.83%
31 Dec, 1442.55%-

As of 30 Jun 24, Atara Biotherapeutics is held by 0.13% institutional shareholders, representing a 0.00% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 241-97.62%
31 Mar, 2442-8.70%
31 Dec, 2346-11.54%
30 Sep, 2352-10.34%
30 Jun, 2358-3.33%
31 Mar, 2360-9.09%
31 Dec, 2266-31.96%
30 Sep, 229744.78%
30 Jun, 2267-8.22%
31 Mar, 22735.80%
31 Dec, 21694.55%
30 Sep, 2166-
30 Jun, 2166-24.14%
31 Mar, 21872.35%
31 Dec, 20851.19%
30 Sep, 2084-8.70%
30 Jun, 209231.43%
31 Mar, 20704.48%
31 Dec, 1967-17.28%
30 Sep, 19816.58%
30 Jun, 197610.14%
31 Mar, 19699.52%
31 Dec, 18638.62%
30 Sep, 1858-28.40%
30 Jun, 1881-14.74%
31 Mar, 1895115.91%
31 Dec, 174412.82%
30 Sep, 1739-13.33%
30 Jun, 1745-2.17%
31 Mar, 1746-11.54%
31 Dec, 165233.33%
30 Sep, 1639-26.42%
30 Jun, 165329.27%
31 Mar, 1641-21.15%
31 Dec, 1552-30.67%
30 Sep, 15758.70%
30 Jun, 156960.47%
31 Mar, 154310.26%
31 Dec, 1439-

1 institutional shareholders have increased their position in ATRA stock as of 30 Jun 24 compared to 42 in the previous quarter (a -97.62% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 242-92.86%
31 Mar, 2428-15.15%
31 Dec, 2333-10.81%
30 Sep, 2337-11.90%
30 Jun, 23422.44%
31 Mar, 2341-21.15%
31 Dec, 225267.74%
30 Sep, 2231-24.39%
30 Jun, 2241-8.89%
31 Mar, 2245-2.17%
31 Dec, 2146-2.13%
30 Sep, 2147-9.62%
30 Jun, 215226.83%
31 Mar, 2141-6.82%
31 Dec, 204415.79%
30 Sep, 203880.95%
30 Jun, 2021-12.50%
31 Mar, 2024-11.11%
31 Dec, 192758.82%
30 Sep, 1917-32.00%
30 Jun, 1925-37.50%
31 Mar, 1940-2.44%
31 Dec, 184146.43%
30 Sep, 1828-9.68%
30 Jun, 183193.75%
31 Mar, 1816-33.33%
31 Dec, 1724-
30 Sep, 1724-
30 Jun, 172420.00%
31 Mar, 172011.11%
31 Dec, 1618-18.18%
30 Sep, 1622175.00%
30 Jun, 168-50.00%
31 Mar, 1616-15.79%
31 Dec, 151972.73%
30 Sep, 1511120.00%
30 Jun, 155-37.50%
31 Mar, 158-
31 Dec, 14--

2 institutional shareholders have reduced their position in ATRA stock as of 30 Jun 24 compared to 28 in the previous quarter (a -92.86% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 245-93.98%182,077-99.78%0.13%0.00%1-97.62%2-92.86%
31 Mar, 2483-9.78%83,283,24828.68%78.63%2.13%42-8.70%28-15.15%
31 Dec, 2392-19.30%64,720,313-26.10%60.83%0.88%46-11.54%33-10.81%
30 Sep, 23114-7.32%87,581,757-3.19%83.34%1.10%52-10.34%37-11.90%
30 Jun, 23123-3.91%90,465,542-11.89%87.01%0.89%58-3.33%422.44%
31 Mar, 23128-9.86%102,671,7225.47%98.75%1.11%60-9.09%41-21.15%
31 Dec, 22142-7.19%97,347,726-2.51%94.35%0.99%66-31.96%5267.74%
30 Sep, 2215312.50%99,854,2400.06%97.49%1.01%9744.78%31-24.39%
30 Jun, 22136-5.56%99,795,4551.98%98.22%1.04%67-8.22%41-8.89%
31 Mar, 221440.70%97,854,1682.80%97.15%0.94%735.80%45-2.17%
31 Dec, 211430.70%95,193,1636.14%101.63%1.11%694.55%46-2.13%
30 Sep, 21142-2.07%89,688,1814.34%95.82%1.10%66-47-9.62%
30 Jun, 21145-4.61%85,960,524-0.73%93.28%1.04%66-24.14%5226.83%
31 Mar, 21152-1.30%86,592,906-0.02%94.68%0.92%872.35%41-6.82%
31 Dec, 201546.94%86,611,5055.12%101.54%0.99%851.19%4415.79%
30 Sep, 2014412.50%82,396,7466.21%101.50%0.78%84-8.70%3880.95%
30 Jun, 201289.40%77,576,36123.18%114.12%1.08%9231.43%21-12.50%
31 Mar, 20117-4.88%62,978,1813.03%102.89%0.92%704.48%24-11.11%
31 Dec, 191230.82%61,124,2193.58%106.00%0.92%67-17.28%2758.82%
30 Sep, 19122-3.94%59,010,00617.32%107.45%0.92%816.58%17-32.00%
30 Jun, 191270.79%50,296,6313.05%108.34%0.97%7610.14%25-37.50%
31 Mar, 19126-48,808,9201.15%105.82%0.95%699.52%40-2.44%
31 Dec, 181264.13%48,254,0454.11%105.41%1.01%638.62%4146.43%
30 Sep, 18121-13.57%46,348,383-0.23%102.08%0.93%58-28.40%28-9.68%
30 Jun, 181408.53%46,455,5846.50%104.68%0.86%81-14.74%3193.75%
31 Mar, 1812946.59%43,618,52446.14%110.16%1.10%95115.91%16-33.33%
31 Dec, 17884.76%29,847,30712.26%99.95%1.31%4412.82%24-
30 Sep, 1784-6.67%26,588,7143.29%87.25%1.13%39-13.33%24-
30 Jun, 17902.27%25,741,6927.25%88.01%1.29%45-2.17%2420.00%
31 Mar, 17883.53%24,002,5333.31%82.61%1.28%46-11.54%2011.11%
31 Dec, 168514.86%23,232,7813.72%80.35%1.33%5233.33%18-18.18%
30 Sep, 16741.37%22,400,3252.78%77.78%1.35%39-26.42%22175.00%
30 Jun, 1673-21,794,93010.03%76.03%1.58%5329.27%8-50.00%
31 Mar, 1673-17.98%19,807,4022.82%69.40%1.51%41-21.15%16-15.79%
31 Dec, 1589-4.30%19,264,206-1.34%67.80%1.36%52-30.67%1972.73%
30 Sep, 159319.23%19,526,63448.02%70.56%2.38%758.70%11120.00%
30 Jun, 157847.17%13,191,58117.49%54.46%2.08%6960.47%5-37.50%
31 Mar, 155335.90%11,227,49366.94%51.22%2.83%4310.26%8-
31 Dec, 1439-6,725,410-42.55%-39---

Atara Biotherapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 20, 2024Touchon Pascaldirector, officer President and CEOS-SaleSell81,506$0.62$50.29K1,829,146
May 20, 2024Nguyen AnhCoofficer EVP, Chief Sci. & Tech OfficerS-SaleSell42,899$0.62$26.47K898,498
May 20, 2024Murugan Amarofficer EVP, Chief Legal OfficerS-SaleSell32,401$0.62$19.99K695,120
May 20, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell28,648$0.62$17.68K645,671
May 20, 2024Henrich Jillofficer EVP, Global Head RA & QualityS-SaleSell25,750$0.62$15.89K529,251
Mar 06, 2024Touchon Pascaldirector, officer President and CEOS-SaleSell24,844$0.72$17.89K1,910,652
Mar 06, 2024Nguyen AnhCoofficer EVP, Chief Sci. & Tech OfficerS-SaleSell10,746$0.72$7.74K941,397
Mar 06, 2024Murugan Amarofficer EVP, Chief Legal OfficerS-SaleSell10,044$0.72$7.23K727,521
Mar 06, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell1,462$0.72$1.05K679,536
Mar 06, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell5,217$0.72$3.76K674,319
Mar 06, 2024Henrich Jillofficer EVP, Global Head RA & QualityS-SaleSell3,879$0.72$2.79K555,001

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Touchon Pascaldirector, officer President and CEOD-ReturnSell9,000$510.75$4.60M-
Aug 14, 2024Touchon Pascaldirector, officer President and CEOD-ReturnSell9,680$303.75$2.94M-
Aug 14, 2024Touchon Pascaldirector, officer President and CEOD-ReturnSell7,075$427.63$3.03M-
May 20, 2024Touchon Pascaldirector, officer President and CEOS-SaleSell81,506$0.62$50.29K1,829,146
May 20, 2024Nguyen AnhCoofficer EVP, Chief Sci. & Tech OfficerS-SaleSell42,899$0.62$26.47K898,498
May 20, 2024Murugan Amarofficer EVP, Chief Legal OfficerS-SaleSell32,401$0.62$19.99K695,120
May 20, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell28,648$0.62$17.68K645,671
May 20, 2024Henrich Jillofficer EVP, Global Head RA & QualityS-SaleSell25,750$0.62$15.89K529,251
Mar 06, 2024Touchon Pascaldirector, officer President and CEOS-SaleSell24,844$0.72$17.89K1,910,652
Mar 06, 2024Nguyen AnhCoofficer EVP, Chief Sci. & Tech OfficerS-SaleSell10,746$0.72$7.74K941,397
Mar 06, 2024Murugan Amarofficer EVP, Chief Legal OfficerS-SaleSell10,044$0.72$7.23K727,521
Mar 06, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell1,462$0.72$1.05K679,536
Mar 06, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell5,217$0.72$3.76K674,319
Mar 06, 2024Henrich Jillofficer EVP, Global Head RA & QualityS-SaleSell3,879$0.72$2.79K555,001

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Touchon Pascaldirector, officer President and CEOD-ReturnSell9,000$510.75$4.60M-
Aug 14, 2024Touchon Pascaldirector, officer President and CEOD-ReturnSell9,680$303.75$2.94M-
Aug 14, 2024Touchon Pascaldirector, officer President and CEOD-ReturnSell7,075$427.63$3.03M-
May 20, 2024Touchon Pascaldirector, officer President and CEOS-SaleSell81,506$0.62$50.29K1,829,146
May 20, 2024Nguyen AnhCoofficer EVP, Chief Sci. & Tech OfficerS-SaleSell42,899$0.62$26.47K898,498
May 20, 2024Murugan Amarofficer EVP, Chief Legal OfficerS-SaleSell32,401$0.62$19.99K695,120
May 20, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell28,648$0.62$17.68K645,671
May 20, 2024Henrich Jillofficer EVP, Global Head RA & QualityS-SaleSell25,750$0.62$15.89K529,251
Apr 02, 2024Fust Matthew Kdirector-A-AwardBuy150,000--259,000
Apr 02, 2024HEIDEN WILLIAM Kdirector-A-AwardBuy150,000--359,000
Apr 02, 2024Roncarolo Maria Graziadirector-A-AwardBuy150,000--238,500
Apr 02, 2024Gallagher Carol Giltnerdirector-A-AwardBuy150,000--629,608
Apr 02, 2024MALLIK AMEETdirector-A-AwardBuy150,000--227,500
Mar 06, 2024Touchon Pascaldirector, officer President and CEOS-SaleSell24,844$0.72$17.89K1,910,652
Mar 06, 2024Nguyen AnhCoofficer EVP, Chief Sci. & Tech OfficerS-SaleSell10,746$0.72$7.74K941,397
Mar 06, 2024Murugan Amarofficer EVP, Chief Legal OfficerS-SaleSell10,044$0.72$7.23K727,521
Mar 06, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell1,462$0.72$1.05K679,536
Mar 06, 2024Hyllengren Eric Jofficer EVP, CFOS-SaleSell5,217$0.72$3.76K674,319
Mar 06, 2024Henrich Jillofficer EVP, Global Head RA & QualityS-SaleSell3,879$0.72$2.79K555,001
Jan 09, 2024Touchon Pascaldirector, officer President and CEOA-AwardBuy1,280,000--1,935,496

The last insider sell of Atara Biotherapeutics's stock was made by Touchon Pascal on Aug 14 2024, selling 9,000 shares at $510.75 per share (valued at $4.60M).

Atara Biotherapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-3-
Q2 2024-5-
Q1 2024106166.67%
Q4 20234666.67%
Q3 2023-12-
Q2 2023142653.85%
Q1 202387114.29%
Q4 2022-8-
Q3 2022-6-
Q2 2022158187.50%
Q1 20221312108.33%
Q4 202131323.08%
Q3 202121020.00%
Q2 20211910190.00%
Q1 20211413107.69%
Q4 202021315.38%
Q3 2020-4-
Q2 2020186300.00%
Q1 202095180.00%
Q3 2019-1-

0 total buy trades, and 3 total sell trades (buy/sell ratio of 0.00%) were made by Atara Biotherapeutics's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024-5-
Q1 2024-6-
Q4 20234666.67%
Q3 2023-12-
Q2 2023-7-
Q1 2023-5-
Q4 2022-6-
Q3 2022-5-
Q2 2022-8-
Q1 2022-9-
Q4 2021-9-
Q3 2021-8-
Q2 202131030.00%
Q1 2021-9-
Q4 2020-7-
Q3 2020-3-
Q2 2020-6-
Q1 2020-4-
Q3 2019-1-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Atara Biotherapeutics's stocks.

Atara Biotherapeutics Peer Ownership


TickerCompany
SANASana Biotechnology, Inc.
XFORX4 Pharmaceuticals, Inc.
BTAIBioXcel Therapeutics, Inc.
VECTVectivBio Holding AG
MREOMereo BioPharma Group plc
FATEFate Therapeutics, Inc.
APLSApellis Pharmaceuticals, Inc.
TCRXTScan Therapeutics, Inc.
RCUSArcus Biosciences, Inc.
HOOKHOOKIPA Pharma Inc.
HRTXHeron Therapeutics, Inc.
KPTIKaryopharm Therapeutics Inc.
CRBUCaribou Biosciences, Inc.
ALLOAllogene Therapeutics, Inc.
ABOSAcumen Pharmaceuticals, Inc.
ITOSiTeos Therapeutics, Inc.
GRTXGalera Therapeutics, Inc.

ATRA Ownership FAQ


Atara Biotherapeutics is owned by institutional shareholders (0.13%), insiders (22.15%), and public (77.72%). The largest institutional shareholder of Atara Biotherapeutics is BOXER CAPITAL, LLC (0.12% of total shares) and the top mutual fund owner is WASATCH FUNDS TRUST (0.72% of total shares).

Atara Biotherapeutics's major institutional shareholders are BOXER CAPITAL, LLC, LAKE STREET ADVISORS GROUP, LLC, IFP ADVISORS, INC, CWM, LLC, and EVERSOURCE WEALTH ADVISORS, LLC. The top five shareholders own together 0.13% of the company's share outstanding.

As of Jun 2024, there are 5 institutional shareholders of Atara Biotherapeutics.

BOXER CAPITAL, LLC owns 166K shares of Atara Biotherapeutics, representing 0.12% of the company's total shares outstanding, valued at $1.41M (as of Jun 2024).

As of Jun 2024, LAKE STREET ADVISORS GROUP, LLC holds 11K shares of Atara Biotherapeutics (ATRA), compromising 0.01% of the company, valued at $93.5K.

IFP ADVISORS, INC is the third largest holder of Atara Biotherapeutics. The company owns 4.5K of the company's shares outstanding (worth $1.76K).